At Xcel, our core objective is to help entrepreneurs build a truly great company.
Xcel focuses on investing and providing long-term and in-depth support for these outstanding companies. We emphasize "team, market, innovation", grow together with the company, and help the company achieve the product-market fit and scalability.
With years of operation, we have built a leading portfolio value-creation team, bring together investors, startups, corporate executives and industry experts. Our acceleration program provides ongoing supports for each portfolio company.
Based in both China and North America, Xcel focuses on seeking investment opportunities in evolving investment thesis, and assisting entrepreneurs to accelerate globalization and achieve multilateral synergies and success.
Company Details
- Employees
- 3
- Address
- 29f, International Financial Center, No.82 Zhanhong Road, Xiamen,fujian,china
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- xcelaccelerator.com
- Keywords
- Ribocure Pharmaceuticals AB.
- HQ
- Xiamen, Fujian
- Competitors
- Ribocure Pharmaceuticals AB, Guidehouse, VanEck, Xcel Capital.
Xcel Capital壹仲中国 Questions
Xcel Capital壹仲中国's website is xcelaccelerator.com
Xcel Capital壹仲中国's LinkedIn profile is https://cn.linkedin.com/company/xcelcapital
Xcel Capital壹仲中国 has
3 employees.
View email and phone details for 3
employees at Xcel Capital壹仲中国.
Xcel Capital壹仲中国's industry is
Venture Capital and Private Equity Principals
Xcel Capital壹仲中国's top competitors are
Ribocure Pharmaceuticals Ab,
Guidehouse,
Vaneck,
Xcel Capital.
Xcel Capital壹仲中国's categories are Venture Capital and Private Equity Principals
